PAN
- Product code
- PAN
- Device name
- Braf Mutation Kit
- Device class
- Class N
- Medical specialty
- Unknown
- Marketing pathway
- Contact ODE
FDA classification definition
The BRAF mutation kit is a multiplex qualitative in vitro diagnostic device to identify specific BRAF mutations by multiplex polymerase chain reaction of genomic DNA extracted from formalin-fixed paraffin-embedded (FFPE) colorectal cancer or fine needle aspirated (FNA) thyroid tissue. It is intended to aid in the treatment decisions and risk stratification of patients diagnosed with colorectal or papillary thyroid cancer.
Official FDA classification page: PAN
Classification and pathway per current FDA publications. Data from openFDA (CC0).